Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;54(1):92-99.
doi: 10.5152/eurasianjmed.2022.20394.

Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass

Affiliations

Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass

Rizal Muhammad et al. Eurasian J Med. 2022 Feb.

Abstract

Vasoplegia is defined by hypotension and low systemic vascular resistance despite the normal or elevated cardiac index, a complication frequently following cardiac surgery, carrying high morbidity and mortality rate. Vasoplegia is related with a profound systemic inflammatory response and is mainly mediated by cellular hyperpolarization, a relative vasopressin deficiency, and high levels of inducible nitric oxide, following cardiopulmonary bypass. Cardiopulmonary bypass is a distinct precipitant of vasoplegia, generally due to its association with nitric oxide production and severe vasopressin depletion. Postoperative vasoplegia is usually managed with vasopressors, of which catecholamines are the traditional agents of choice. Recent studies promote the use of non-catecholamine vasopressor (vasopressin) in restoring systemic vascular resistance. Alternative agents are also able to restore vascular tone and improve vasoplegia, including methylene blue, angiotensin II, hydroxocobalamin, and ascorbic acid; however, their effect on patient outcomes is still unclear .

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
The cellular mechanism of vasodilatory shock. The smooth muscles of blood vessels contract when intracellular calcium levels rise and cause cross bonds between actin and myosin, which are phosphorylated. This process is triggered after vasoconstrictive mediators, such as angiotensin II or catecholamines, bind to surface receptors. Conversely, vasodilation occurs when molecules such as a nitric oxide or atrial natriuretic peptides produce an increase in intracellular cyclic guanosine monophosphate (cGMP) and deposition of myosin.
Figure 2.
Figure 2.
The mechanism of CPB-associated vasoplegia. Cardiopulmonary bypass triggers a severe inflammatory reaction that increases NO production, ATP depletion, and an increase in the vascular smooth muscle acidemia, which results in decreased myosin phosphorylation and vasodilation. Simultaneously, neuro-hypophyseal deposits from endogenous vasopressin are depleted rapidly, adding to the vasodilation effect and creating vasoplegia. ATP: adenosine triphosphate, cGMP: cyclic guanosine monophosphate, CPB: cardiopulmonary bypass; KATP: ATP-sensitive potassium channel.

Similar articles

Cited by

References

    1. Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018;22(1):174. 10.1186/s13054-018-2102-1). - DOI - PMC - PubMed
    1. Shaefi S, Mittel A, Klick J.et al. Vasoplegia After cardiovascular procedures—pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth. 2018;32(2):1013 1022. 10.1053/j.jvca.2017.10.032). - DOI - PubMed
    1. Omar S, Zedan A, Nugent K. Cardiac Vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. Januarie. 2015;349(1):80 88. 10.1097/MAJ.0000000000000341) - DOI - PubMed
    1. Charles FG, Murray LJ, Giordano C, Spiess BD. Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms. Can J Anaesth. 2019;66(12):1501 1513. 10.1007/s12630-019-01449-x) - DOI - PubMed
    1. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. Epstein FH, redakteur. N Engl J Med. 2001;345(8):588 595. 10.1056/NEJMra002709) - DOI - PubMed

LinkOut - more resources